Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Multi-center, Randomized Controlled Trial Comparing Pregnancy Outcomes Following Selection and Single Embryo Transfer (SET) Based on Preimplantation Genetic Screening (PGS) by Next Generation Sequencing (NGS) Versus Standard Morphological Assessment

NCT02268786 is registered in ClinicalTrials.gov with Illumina, Inc. as lead sponsor.

NCT NCT02268786
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02268786 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Multi-center, Randomized Controlled Trial Comparing Pregnancy Outcomes Following Selection and Single Embryo Transfer (SET) Based on Preimplantation Genetic Screening (PGS) by Next Generation Sequencing (NGS) Versus Standard Morphological Assessment
Lead sponsor
Illumina, Inc.
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2014
Completion date
December 31, 2016
Enrollment
661 (actual)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

aneuploidy, infertility